Melanoma
Integrative Treatment Options for All Stages of Melanoma
Why Stage IV Melanoma Often Requires a More Personalized Treatment Strategy
Once melanoma spreads beyond the skin to distant lymph nodes or organs, treatment becomes significantly more complex. Every patient's cancer is different, and factors such as previous treatments, tumor biology, immune function, and the location of metastatic disease all influence which treatment strategies may be most appropriate.
Many patients are surprised to learn that additional integrative treatment options may still be available, even after surgery, checkpoint inhibitor immunotherapy, targeted therapy, chemotherapy, or radiation. Depending on your diagnosis, previous treatments, and overall health, physicians may recommend one or more of the following treatment approaches.
Every patient's care plan is tailored to their diagnosis, stage of disease, prior treatments, treatment goals, and overall health. The best outcomes begin with treating the whole person, not just the disease.
Personalized Immunotherapy
Designed to help the immune system recognize and respond to cancer cells using advanced cellular immunotherapy strategies.
- Dendritic Cell Therapy - trains the immune system to recognize cancer cells as abnormal and launch a targeted immune response.
- LAK Cell Therapy - Activates the patient's immune cells to support the body's natural response to abnormal cells.
- TIL Therapy - Uses the patient's own tumor-infiltrating immune cells to support the body's response to abnormal cells.
- Tumor Lysate Cell Therapy - Uses tumor-derived proteins to help the immune system recognize abnormal cells.
- (NK) Cell Therapy - Supports the activity of NK cells to promote healthy immune function.
Integrative Oncology: Low-Dose Metronomic Chemotherapy
- Leverages Cancer's High Sugar Demand – Many cancer cells consume significantly more glucose than healthy cells. Low-Dose Metronomic Chemotherapy is designed to take advantage of this metabolic difference.
- Insulin Creates a Treatment Window – A carefully controlled dose of insulin briefly lowers blood sugar, creating a short period when cancer cells naturally increase glucose uptake.
- Low-Dose Chemotherapy Is Carefully Timed – Chemotherapy is administered during this window with the goal of increasing uptake by cancer cells while using a lower overall dose.
- Designed to Reduce Treatment Burden – By using lower chemotherapy doses when appropriate, Low-Dose Metronomic Chemotherapy aims to reduce side effects while maintaining therapeutic intent.
- Part of a Comprehensive Integrative Plan – Low-Dose Metronomic Chemotherapy is coordinated with immunotherapy, hyperthermia, ozone therapy, high-dose IV Vitamin C, nutrition, and metabolic support to create a personalized treatment strategy.
Holistic Therapy
Supportive therapies may include:
- Specific Natural IVs
- Repurposed Medications
- Clinical nutrition
- Targeted supplementation
- Hyperthermia
- Ozone therapy (if applicable)
- Detoxification support
- Mind-body therapies
Become a patient today and start your personalized holistic cancer treatment with expert guidance from our medical professionals. Call us at: 623-294-8096 or fill out the form and we'll reach out to you.
Comprehensive Testing to Personalize Your Treatment Strategy
Every patient responds to cancer differently. That's why a comprehensive evaluation may include specialized laboratory testing, imaging, and biomarker analysis to better understand your cancer, your overall health, and which integrative therapies may be most appropriate for your individual situation.
Depending on your diagnosis and previous treatments, physicians may recommend:
- Circulating Tumor Cell (CTC) Testing to evaluate circulating cancer cells.
- Tumor Marker Analysis to monitor disease activity and treatment response.
- Nutritional & Metabolic Profiling to identify nutritional deficiencies and metabolic factors that may influence overall health.
- Genetic Testing to help personalize treatment recommendations when appropriate.
- Comprehensive Blood Testing to evaluate immune function, organ health, inflammation, hormone balance, and determine eligibility for certain therapies.
- Advanced Imaging Studies such as PET scans, CT scans, ultrasound, or X-rays to evaluate the extent of disease and monitor progress throughout treatment.
The results help physicians develop a personalized treatment strategy tailored to your diagnosis, previous treatments, overall health, and treatment goals, helping identify the integrative therapies that may be most appropriate for your individual situation.
You May Have More Treatment Options Than You Realize
A diagnosis of Stage IV melanoma can leave patients and families feeling overwhelmed. The sooner you understand your options, the sooner you can make informed decisions about your next steps.
A no-pressure consultation gives you the opportunity to discuss your diagnosis, previous treatments, personal goals, and any medical, financial, or travel considerations that may influence your treatment decisions.
If appropriate, we'll help connect you with a physician whose treatment philosophy aligns with your individual situation.
Call us at 623-294-8096 or complete the form to schedule your consultation.
References:
“Cancer Stat Facts: Melanoma of the Skin.” National Cancer Institute, https://seer.cancer.gov/statfacts/html/melan.html. Accessed 20 September 2022.
“Melanoma.” The Cleveland Clinic, https://my.clevelandclinic.org/health/diseases/14391-melanoma. Accessed 20 September 2022.
“What to look for: ABCDEs of melanoma.” American Academy of Dermatology Association,
https://www.aad.org/public/diseases/skin-cancer/find/at-risk/abcdes. Accessed 20 September 2022.
“Melanoma.” Mayo Clinic, https://www.mayoclinic.org/diseases-conditions/melanoma/symptoms-causes/syc-20374884. Accessed 20 September 2022.
Chinembiri, Tawona N et al. “Review of natural compounds for potential skin cancer treatment.” Molecules (Basel, Switzerland) vol. 19,8 11679-721. 6 Aug. 2014, doi:10.3390/molecules190811679.
Kranjc, Simona et al. “Electrochemotherapy by pulsed electromagnetic field treatment (PEMF) in mouse melanoma B16F10 in vivo.” Radiology and oncology vol. 50,1 39-48. 16 Feb. 2016, doi:10.1515/raon-2016-0014.
Kapoor, Shailendra. “The Anti-neoplastic Effects of Alpha-Lipoic Acid: Clinical Benefits in System Tumors besides Lung Carcinomas.” The Korean journal of thoracic and cardiovascular surgery vol. 46,2 (2013): 162-3. doi:10.5090/kjtcs.2013.46.2.162.
Baldari, Silvia et al. “Current Biomedical Use of Copper Chelation Therapy.” International journal of molecular sciences vol. 21,3 1069. 6 Feb. 2020, doi:10.3390/ijms21031069.
“Mistletoe (European).” Memorial Sloan Kettering Cancer Center, https://www.mskcc.org/cancer-care/integrative-medicine/herbs/mistletoe-european. Accessed 20 September 2022.

